Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Dec;38(4):218-23.
doi: 10.4143/crt.2006.38.4.218. Epub 2006 Dec 31.

Prognostic significance of immunohistochemical expression of p53 gene product in operable breast cancer

Hong Suk Song  1 , Young Rok Do, Sun Hee Kang, Ki Yong Jeong, Yu Sa Kim
Affiliations

Prognostic significance of immunohistochemical expression of p53 gene product in operable breast cancer

Hong Suk Song et al. Cancer Res Treat. 2006 Dec.

Abstract

Purpose: The aim of this study was to investigate the prognostic significance of the expression of p53 gene product in operable invasive breast cancer by performing immunohistochemical analysis.

Materials and methods: Between January 1993 and December 2001, 440 operable invasive breast cancer patients underwent immunohistochemical staining for p53, and we retrospectively analyzed these results together with the clinical outcomes.

Results: The overexpression of p53 was detected in 51.6% of the cases. The overexpression of p53 was inversely correlated with lymph node metastasis (p=0.005). The tumor size, tumor histology, histologic grade, hormonal receptor status and tumor stage were not related to the overexpression of p53. Multivariate Cox regression analysis indicate that lymph node metastasis, tumor size and the p53 expression were the significant prognostic factors for overall survival; lymph node metastasis, the estrogen receptor status and the p53 expression were the significant prognostic factors for relapse free survival. On the subgroup analysis, the p53 non-expressors showed better 7-year overall survival (92.7% vs. 76.7%, respectively, p=0.011) and relapse free survival (74.9% vs. 57.8%, respectively, p=0.032) than did the p53 overexpressors for the patients with lymph node metastasis. However, for the patients without lymph node metastasis, the survival rates were not different for both the p53 non-expressors and the p53 overexpressors.

Conclusion: Immunohistochemical staining of the p53 gene product was an independent prognostic factor for predicting survival of the lymph node positive invasive breast cancer patients.

Keywords: Breast neoplasms; Immunohistochemistry; Prognosis; p53.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Kaplan-Meier overall survival curve in operable breast cancer patients according to p53 expression.
Fig. 2
Fig. 2
Kaplan-Meier overall survival curve in operable lymph node-negative and lymph node-positive breast cancer patients according to p53 expression.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Adair FE, Berg J, Joubert L, Robbins GF. Long-term follow-up of breast cancer patients: the 30-year report. Cancer. 1974;33:1145–1150. - PubMed
    1. Friedrichs K, Gluba S, Eidtmann H, Jonat W. Overexpression of p53 and prognosis in breast cancer. Cancer. 1993;72:3641–3647. - PubMed
    1. Iggo R, Gatter K, Bartek J, Lane DP, Harris AL. Increased expression of mutant form of p53 oncogene in primary lung cancer. Lancet. 1990;335:675–679. - PubMed
    1. Finlay CA, Hinds PW, Levine AJ. The p53 proto-oncogene can act as a suppressor of transformation. Cell. 1989;57:1083–1093. - PubMed
    1. Davidoff AM, Herndon JE, Glover NS, Kerns BJM, Pence JC, Iglehart JD, et al. Relation between p53 overexpression and established prognostic factors in breast cancer. Surgery. 1991;110:259–264. - PubMed